[
 {
  "title": "Benefits of Continuous Glucose Monitor",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "The remarkable benefits of a continuous glucose monitor for the diabetes population. The impact of sleep and stress on glucose as well as the unmatched power of a CGM to drive behavioral change. The exciting partnerships and future advancements of their products benefiting not only those with type 1 and 2 diabetes, but also for the growing community of people interested in optimizing health and wellness.",
  "content_length": 407,
  "content_tokens": 71,
  "embedding": []
 },
 {
  "title": "CGM Technology and its Advancements",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "How CGM technology works, and what makes Dexcom’s G6 the best model yet. Challenges of working in the US healthcare system and getting CGM insured. Developing an even smaller, more user-friendly, and less costly product while maintaining performance and accuracy. The incredible accuracy of the G6, recommended over-the-counter glucose meters, and the unmatched power of CGM to drive behavioral change.",
  "content_length": 402,
  "content_tokens": 85,
  "embedding": []
 },
 {
  "title": "Software Improvements for Type 2 Diabetics",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Software improvements for type 2 diabetics, and the remarkable benefits of real-time feedback for driving behavioral change.",
  "content_length": 124,
  "content_tokens": 23,
  "embedding": []
 },
 {
  "title": "Future of CGM",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Dexcom vs. the competitors, the less invasive options, and the fundamental problems needing to be solved with CGM technologies. The cost of CGM, why you need a prescription, and when might there be a OTC option? Smartwatch integration, bluetooth technology, and exciting collaborations and partnerships. Future places for CGM: Hospitals, nutrition apps, general health and wellness, and more.",
  "content_length": 392,
  "content_tokens": 81,
  "embedding": []
 },
 {
  "title": "Safety Information for Dexcom G6 System",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "The Dexcom G6 Continuous Glucose Monitoring System (Dexcom G6 System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons age 2 years and older. Do not use the G6 if you are pregnant, on dialysis, or critically ill. It is not known how different conditions or medications common to theses populations may affect performance of the system. G6 readings may be inaccurate in these populations. The system requires a prescription.",
  "content_length": 479,
  "content_tokens": 97,
  "embedding": []
 },
 {
  "title": "Continuous Glucose Monitor Benefits",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Discusses the remarkable benefits of a continuous glucose monitor for the diabetes population. The impact of sleep and stress on glucose as well as the unmatched power of a continuous glucose monitor to drive behavioral change. Reveals some of the exciting partnerships and future advancements of their products benefiting not only those with type 1 and 2 diabetes, but also for the growing community of people interested in optimizing health and wellness.",
  "content_length": 456,
  "content_tokens": 78,
  "embedding": []
 },
 {
  "title": "CGM Technology",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Explains how CGM technology works, and what makes Dexcom’s G6 the best model yet. Discusses the challenges of working in the US healthcare system and getting CGM insured. Talks about developing an even smaller, more user-friendly, and less costly product while maintaining performance and accuracy.",
  "content_length": 298,
  "content_tokens": 62,
  "embedding": []
 },
 {
  "title": "Future of CGM",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Discusses the next thing on the horizon for type 1 diabetes patients. Talks about the incredible accuracy of the G6, recommended over-the-counter glucose meters, and the unmatched power of CGM to drive behavioral change. Discusses software improvements for type 2 diabetics, and the remarkable benefits of real-time feedback for driving behavioral change.",
  "content_length": 355,
  "content_tokens": 70,
  "embedding": []
 },
 {
  "title": "CGM vs Competitors",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Compares Dexcom vs. the competitors, the less invasive options, and the fundamental problems needing to be solved with CGM technologies. Discusses the cost of CGM, why you need a prescription, and when might there be a OTC option.",
  "content_length": 230,
  "content_tokens": 51,
  "embedding": []
 },
 {
  "title": "CGM Integration and Partnerships",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Talks about smartwatch integration, bluetooth technology, and exciting collaborations and partnerships. Discusses future places for CGM: Hospitals, nutrition apps, general health and wellness, and more.",
  "content_length": 202,
  "content_tokens": 39,
  "embedding": []
 },
 {
  "title": "Dexcom G6 CGM",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "It’s an enzymatic reaction which means that it can be done without multiple washes. This device can’t measure lipoproteins or insulin. The insertion technology of the sensor, it goes in with a needle and the needle comes out. The needle is in your skin less time that it takes a hummingbird to flap its wings a couple of times so a patient doesn’t feel it. And then the sensor rests in the subcutaneous tissue and you really don’t feel that sensor at all. Most CGM (and even the previous Dexcom G5) are a bit uncomfortable.",
  "content_length": 523,
  "content_tokens": 128,
  "embedding": []
 },
 {
  "title": "Accuracy of Dexcom G6",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "What makes the G6 so accurate compared to previous models and competitors is the new membrane technology and new algorithm.",
  "content_length": 123,
  "content_tokens": 22,
  "embedding": []
 },
 {
  "title": "Diabetes and CGM Usage",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "In the United States, between 1.3-2 million have type 1 diabetes and 1.5 million who intensively use insulin have type 2 diabetes. Between 20 and 30% of these patients use a CGM. These percentages have grown rapidly over the past couple of years as we’ve gotten better and as other products of come to the market.",
  "content_length": 313,
  "content_tokens": 72,
  "embedding": []
 },
 {
  "title": "Insurance for Type 2 Diabetes",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "In January of 2017, they approved the use of CGM for “intensive insulin using” type 2 diabetes patients. That was a step that we really needed. As the technology advances, more and more people are able to take advantage of the easy use and practicality. But insurance is paying for these at such an increasing rate that they try to “slow down” the use of them. So it is a constant battle with between doctors and insurance companies to get the patients covered.",
  "content_length": 461,
  "content_tokens": 100,
  "embedding": []
 },
 {
  "title": "Cost Savings with CGM",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Looking at A1C, studies show at least a half a point drop over the course of a twelve month period, compared to multiple finger sticks. A full point drop for the patient’s, if you just look at them independently on continuous glucose monitoring use for a six-month period that is sustained. And that drop in A1C leads to reduced costs in the healthcare system.",
  "content_length": 360,
  "content_tokens": 79,
  "embedding": []
 },
 {
  "title": "Challenges with Insurance Companies",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Insurance companies have a short-term outlook. A 25 year-old probably isn’t generating all those complications yet. And a 25 year-old is with an insurance plan for two years before they move to their next job, and they’re on another insurance plan for two years. In other words, the insurance company doesn’t care if they get sick in 30 years, they only care about the next couple years.",
  "content_length": 387,
  "content_tokens": 90,
  "embedding": []
 },
 {
  "title": "Future Developments in CGM",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "The next thing on the horizon for type one diabetes is to develop algorithms to go with the sensor for automated insulin delivery. Currently, the G6 will tell you glucose value, the trend, the speed at which you are going up and down. It will give you alerts and alarms based on what’s going on. But we don’t tell you what to do.",
  "content_length": 329,
  "content_tokens": 77,
  "embedding": []
 },
 {
  "title": "CGM and A1C Reduction",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "CGM can reduce A1C (even if only 8.0 to 7.8 that can make a big difference in long run). Reduction in incidences of “bad outcomes” like hypoglycemia and hyperglycemia.",
  "content_length": 167,
  "content_tokens": 50,
  "embedding": []
 },
 {
  "title": "Accuracy of the Dexcom G6",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "You are able to calibrate the G6 daily. The reliable nature of the G6 allows for patients to stop doing their finger sticks which can be incredibly painful. The new algorithms can identify a finger stick that is inaccurate (when trying to calibrate the CGM).",
  "content_length": 258,
  "content_tokens": 54,
  "embedding": []
 },
 {
  "title": "CGM as a Driver of Behavioral Change",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "The use of a CGM, at the very least, is a powerful driver of behavioral change. It is really hard to not pay attention to how activities in your life, mostly food, but not just food, stress affects your glucose readings.",
  "content_length": 220,
  "content_tokens": 49,
  "embedding": []
 },
 {
  "title": "Stress and Glucose Levels",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "It’s amazing what stress can do to your glucose level. Doing his own measurements, Peter was able to correlate his nighttime cortisol levels to how much glucose level would rise in the morning.",
  "content_length": 193,
  "content_tokens": 39,
  "embedding": []
 },
 {
  "title": "Glucose Levels and Stress",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "A fasting glucose of 100 instead of being 90 can very easily be explained by cortisol or hepatic glucose output for some other reason that’s not a function of insulin resistance. The impact of a stressful dental procedure can ramp up cortisol production and hepatic glucose output, increasing glucose levels.",
  "content_length": 308,
  "content_tokens": 58,
  "embedding": []
 },
 {
  "title": "Effects of Junk Food on Glucose Levels",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Consumption of junk food like trail mix or yogurt covered raisins can cause glucose levels to spike significantly. This can lead to an insulin overshoot and a subsequent drop in glucose levels.",
  "content_length": 193,
  "content_tokens": 38,
  "embedding": []
 },
 {
  "title": "Type 2 Diabetes and Therapies",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "The real problem in type 2 diabetes is that we have fixated so much on just the glucose and not worrying about how we get there. Drugs that increase endogenous insulin production can reduce the glucose and reduce the microvascular complications, but do not save lives. The real challenge in type 2 diabetes is the combination of the hyperglycemia with the hyperinsulinemia. Therapies that save lives with type 2 diabetes include Metformin and the SGLT2 inhibitors.",
  "content_length": 464,
  "content_tokens": 98,
  "embedding": []
 },
 {
  "title": "Estimating Average Insulin Production",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "It is believed that it’s possible to measure how quickly insulin reacts and how much by the slope of the glucose curves, but not at five-minute measurement intervals.",
  "content_length": 166,
  "content_tokens": 35,
  "embedding": []
 },
 {
  "title": "Real Time Feedback and Behavioral Change",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Real time feedback can be a driver of behavioral change. For example, seeing the impact of certain foods on glucose levels can lead to changes in dietary habits.",
  "content_length": 161,
  "content_tokens": 31,
  "embedding": []
 },
 {
  "title": "Software Improvements for Type 2 Diabetics",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Software improvements for type 2 diabetics could include an analysis at the end of the day where we complement somebody, prompts from the monitor to help you do better, and integrating the CGM data into a food database with photos.",
  "content_length": 231,
  "content_tokens": 46,
  "embedding": []
 },
 {
  "title": "Exercise, Stress and Glucose Levels",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Exercise and stress can significantly impact glucose levels. It’s not just what you eat, but it’s the physiologic state you are in when you eat it. The correlation between high glucose levels and poor sleep quality is also significant.",
  "content_length": 235,
  "content_tokens": 51,
  "embedding": []
 },
 {
  "title": "Continuous Glucose Monitoring Technologies",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Continuous Glucose Monitoring (CGM) technologies need to solve problems related to accuracy, convenience, cost, and healthcare outcomes. The cost of the CGM is the biggest barrier to getting more users. Additionally, you need a prescription, and unless you have diabetes, you will be paying out of pocket for it.",
  "content_length": 312,
  "content_tokens": 65,
  "embedding": []
 },
 {
  "title": "Over-the-Counter CGM",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Over-the-counter CGM would need to fit into the current regulatory environment which means some of the functionality would need to be dumbed down. It would not be a device used for diabetes treatment. The fact that there is a needle that needs to be inserted complicates this issues.",
  "content_length": 283,
  "content_tokens": 58,
  "embedding": []
 },
 {
  "title": "Diabetes Device and Smartwatch Integration",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "The accuracy and performance would still be in line with the diabetes device, but the information that’s presented to the individual would have to be reduced/changed. In part that means you would have to take away the real-time information (and present it a day later). Dexcom is currently working on a “direct to watch” transmitter to send data directly from sensor to the Apple Watch (and other smart watches such as Android). The watch would then become a patient’s receiver and the data could still be shared without having to go through your phone.",
  "content_length": 553,
  "content_tokens": 116,
  "embedding": []
 },
 {
  "title": "Bluetooth Technology in Health Devices",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "G6 can store data and then back load it once it gets within range of your phone. That way people can put their phones in another room while they sleep. The transmission range of our product, I believe it’s labeled for 20 feet. “We went with Bluetooth because we didn’t want our patients to have to put the phone close to the device. We wanted the continuous feed.",
  "content_length": 363,
  "content_tokens": 83,
  "embedding": []
 },
 {
  "title": "Health Partnerships and Collaborations",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Partnership with Verily includes work with a company that they have called Onduo that is focused on type 2 diabetes and specifically developing solutions that could help people make better decisions. Onduo is helping to develop apps that combine everything they’ve learned about diabetes with a lot of Google technology and they’re in pilot phases with various payers on the type 2 side. Doing a lot of work with United Healthcare on type 2 diabetes. In the future with United, planning to develop some prediabetes models as we take this Gen 6 technology out.",
  "content_length": 559,
  "content_tokens": 115,
  "embedding": []
 },
 {
  "title": "Future of CGM in Hospitals",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Had a joint venture with Edwards Lifesciences but the FDA was extremely strict on accuracy and performance and it didn’t quite get there. Learned a lot and now planning to make another attempt with G6. Monitor patients (especially diabetics) and dosing insulin. Connect the Bluetooth to the nurses station so can see glucose in real time. Currently, nurses may have to finger stick a patient every 30 minutes (48 finger sticks in a 24-hour period).",
  "content_length": 448,
  "content_tokens": 96,
  "embedding": []
 },
 {
  "title": "Gestational Diabetes and CGM",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "It’s crazy that pregnant women aren’t able to take advantage of the CGM. But it’s not yet approved for gestational diabetes. Need to run a study in gestational diabetes to get that label. The CGM as a diagnostic. This gets back to hemoglobin A1C and other measures. One of the things that we look at is this product, is it diagnostic as well? Right now you drink that real sugary drink, glucose goes way high, then it goes way low (an awful swing). What about a blinded sensor on somebody for a week? Then develop the algorithms to see what we can predict with respect to gestational diabetes. Those are the type of studies that we want to run in the future and the way we like to go about that market.",
  "content_length": 702,
  "content_tokens": 164,
  "embedding": []
 },
 {
  "title": "Health and Wellness CGM Market",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "Dexcom would like to combine CGM with some of the nutrition apps. For example, Weight Watchers app… If that had glucose data and you ate your 32 points today but your glucose factor was still high, maybe we take you down to 26. And vice versa. CGM can integrate wonderfully (without showing a glucose value that you dose insulin off of).",
  "content_length": 337,
  "content_tokens": 73,
  "embedding": []
 },
 {
  "title": "Lessons from Wearing a CGM",
  "date": "May 20, 2019",
  "context": "Preventing Chronic Disease",
  "people": "Peter Attia",
  "content": "What you learn is going to alter your behavior. You learn other really interesting things: How much even exercise can transiently raise your blood glucose, but what the benefits are after the fact ( which is your ability to dispose of glucose goes up significantly). For Peter, he gets about a 30 point spike in a workout, but for the rest of the his average glucose is about 10 points lower.",
  "content_length": 392,
  "content_tokens": 79,
  "embedding": []
 }
]